OpenAlex
PricingAboutJobs
Log inGet started
Work

A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer

HTML

Year: 2010
Type: article
Study design: Clinical Trial
Source: Gynecologic Oncology
DOI: 10.1016/j.ygyno.2010.05.033
Authors: Michael Friedlander, Kenneth C. Hancock, Danny Rischin, Mark J. Messing, Claude A. Stringer, Gemma M. Matthys, Bo Ma, Jeffrey P. Hodge, Joanne J. Lager
Institutions: Prince of Wales Hospital, Texas Oncology, Mercy Hospital for Women
Language: English

Topic: Ovarian cancer diagnosis and treatment
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: pazopanib, recurrent ovarian cancer, anti-angiogenic therapy, CA-125 response, epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer, peripheral edema
SDG: Good health and well-being

Open Access status: closed

Funder: GlaxoSmithKline
OpenAlex ID: W1994855668
FWCI: 14.13
Cites: 48
Cited by: 235
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms